换一批
换一批Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
作者：
Antonella,Bruzzese [1]
;
Daniele,Derudas [2]
;
Monica,Galli [3]
;
Enrica Antonia,Martino [1]
;
Stefano,Rocco [4]
;
Concetta,Conticello [5]
;
Catello,Califano [6]
;
Nicola,Giuliani [7]
;
Silvia,Mangiacavalli [8]
;
Giuliana,Farina [9]
;
Alessandra,Lombardo [10]
;
Marino,Brunori [11]
;
Elena,Rossi [12]
;
Elisabetta,Antonioli [13]
;
Roberto,Ria [14]
;
Renato,Zambello [15]
;
Nicola,Di Renzo [16]
;
Giuseppe,Mele [17]
;
Gianpaolo,Marcacci [18]
;
Giuseppe,Pietrantuono [19]
;
Gaetano,Palumbo [20]
;
Nicola,Cascavilla [21]
;
Claudio,Cerchione [22]
;
Angelo,Belotti [23]
;
Clelia,Criscuolo [24]
;
Giuseppina,Uccello [25]
;
Paola,Curci [26]
;
Ernesto,Vigna [1]
;
Francesco,Mendicino [1]
;
Enrico,Iaccino [27]
;
Selena,Mimmi [27]
;
Cirino,Botta [1]
;
Donatella,Vincelli [28]
;
Nicola,Sgherza [29]
;
Angela,Bonalumi [26]
;
Luca,Cupelli [30]
;
Raffaella,Stocchi [31]
;
Massimo,Martino [32]
;
Stelvio,Ballanti [33]
;
Dominella,Gangemi [34]
;
Alfredo,Gagliardi [35]
;
Barbara,Gamberi [36]
;
Alessandra,Pompa [37]
;
Giovanni,Tripepi [38]
;
Ferdinando,Frigeri [39]
;
Ugo,Consoli [9]
;
Sara,Bringhen [27]
;
Elena,Zamagni [40]
;
Francesca,Patriarca [41]
;
Valerio,De Stefano [32]
;
Francesco,Di Raimondo [12]
;
Salvatore,Palmieri [5]
;
Maria Teresa,Petrucci [4]
;
Massimo,Offidani [42]
;
Pellegrino,Musto [43]
;
Mario,Boccadoro [26]
;
Michele,Cavo [44]
;
Antonino,Neri [40]
;
Fortunato,Morabito [41]
;
Massimo,Gentile [45]
作者单位：
Hematology Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
[1]
Department of Hematology, Businco Hospital, Cagliari, Italy.
[2]
Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale-Papa Giovanni XXIII, Bergamo, Italy.
[3]
Hematology Unit, Napoli, Italy.
[4]
Department of Medical and Surgical Specialties, Hematology Section, University of Catania, Catania, Italy.
[5]
Onco-hematology Unit, Ospedale Umberto I, Nocera Inferiore, Italy.
[6]
Hematology Unit, Parma University Hospital, Parma, Italy.
[7]
Department of Hematology-Oncology, Hematology Division, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
[8]
UOC Ematologia a Indirizzo Oncologico, AORN "Sant'Anna e San Sebastiano", Caserta, Italy.
[9]
Onco-hematology Unit Azienda Ospedaliera Santa Maria of Terni, Terni, Italy.
[10]
Internal Medicine, Ospedale S. Croce, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Fano, Italy.
[11]
Istituto di Ematologia, Università Cattolica, Fondazione Policlinico Gemelli IRCCS, Roma, Italy.
[12]
Hematology Unit, Careggi Hospital, Florence, Italy.
[13]
Department of Biomedical Science, University of Bari "Aldo Moro" Medical School, Internal Medicine "G. Baccelli", Bari, Italy.
[14]
Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy.
[15]
Hematology Unit, Lecce, Italy.
[16]
Hematology Unit, Brindisi, Italy.
[17]
Hematology and Bone Marrow Transplant Unit, Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS, Napoli, Italy.
[18]
Unit of Hematology and Stem Cell Transplantation, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture (Pz), Italy.
[19]
Department of Hematology, Hospital University Riuniti, Foggia, Italy.
[20]
Department of Hematology and Bone Marrow Transplant, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
[21]
Hematology Unit, IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.
[22]
Hematology Unit, A.O. Spedali Civili, Brescia, Italy.
[23]
Hematology Unit, AO S.G. Moscati, Aversa (CE), Italy.
[24]
Hematology Department, G. Garibaldi Hospital, Catania, Italy.
[25]
Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy.
[26]
Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
[27]
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
[28]
Department of Hemato-Oncology and Radiotherapy, Hematology Unit, Great Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
[29]
Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
[30]
Hematology Unit and Pathology Department, S. Eugenio Hospital Rome, Rome, Italy.
[31]
Hematology, DISM, University of Udine, Udine, Italy.
[32]
Department of Hemato-Oncology and Radiotherapy, Stem Cell Transplantation Unit, Great Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
[33]
Institute of Haematology and Stem Cell Transplantation, Ospedale Santa Maria della Misericordia, University of Perugia, Perugia, Italy.
[34]
Hematology Unit, Fabrizio Spaziani Hospital, Frosinone, Italy.
[35]
Complex Operative Unit of Hematology, S. Maria di Loreto Nuovo Hospital, Napoli, Italy.
[36]
Hematology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
[37]
Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
[38]
Nephrology Center of National Research Institute of Biomedicine and Molecular Immunology, Reggio Calabria, Italy.
[39]
Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
[40]
Seràgnoli Institute of Hematology and Medical Oncology, University of Bologna, Bologna, Italy.
[41]
Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy.
[42]
Hematology Unit, AOU Ospedali Riuniti di Ancona, Foggia, Italy.
[43]
Department of Emergency and Organ Transplantation, "Aldo Moro" University School of Medicine, Bari, Italy.
[44]
Scientific Directorate Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
[45]
Hemato-Oncology Department, Augusta Victoria Hospital of Jerusalem, Jerusalem, Israel.
[46]
Biotechnology Research Unit, AO di Cosenza, Italy.
[47]
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);地塞米松(Dexamethasone);随访研究(Follow-Up Studies);人类(Humans);多发性骨髓瘤(Multiple Myeloma);回顾性研究(Retrospective Studies);沙立度胺(Thalidomide)
DOI
10.1002/hon.3031
PMID
35608183
发布时间
2022-10-11
- 浏览2
Hematological oncology
Hematological oncology
704-715页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
